Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 7 | 98 | 13 | 81 | 102 |
| Cost of Goods | 5 | 62 | 81 | 61 | -41 |
| Gross Profit | 2 | 36 | -68 | 20 | 143 |
| Operating Expenses | 2,115 | 3,555 | 3,346 | 2,443 | 1,154 |
| Operating Income | -2,108 | -3,457 | -3,333 | -2,362 | -1,052 |
| Interest Expense | 381 | 278 | 582 | 1,150 | 1,056 |
| Other Income | 72 | 246 | -426 | 1,442 | 1,829 |
| Pre-tax Income | -2,417 | -3,489 | -4,341 | -2,070 | -279 |
| Net Income Continuous | -2,417 | -3,489 | -4,341 | -2,070 | -279 |
| Net Income | $-2,417 | $-3,489 | $-4,341 | $-2,070 | $-279 |
| EPS Basic Total Ops | -0.05 | -0.07 | -0.15 | -0.18 | -0.04 |
| EPS Basic Continuous Ops | -0.04 | -0.07 | -0.13 | -0.15 | -0.03 |
| EPS Diluted Total Ops | -0.05 | -0.07 | -0.15 | -0.18 | -0.04 |
| EPS Diluted Continuous Ops | -0.04 | -0.07 | -0.13 | -0.15 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.07 | N/A | N/A | N/A |
| EBITDA(a) | $-1,903 | $-3,242 | $-3,118 | $-1,951 | $-556 |